SARS-CoV-2 shifting transmission dynamics and hidden reservoirs potentially limit efficacy of public health interventions in Italy.


Journal

Communications biology
ISSN: 2399-3642
Titre abrégé: Commun Biol
Pays: England
ID NLM: 101719179

Informations de publication

Date de publication:
21 04 2021
Historique:
received: 21 12 2020
accepted: 03 03 2021
entrez: 22 4 2021
pubmed: 23 4 2021
medline: 11 5 2021
Statut: epublish

Résumé

We investigated SARS-CoV-2 transmission dynamics in Italy, one of the countries hit hardest by the pandemic, using phylodynamic analysis of viral genetic and epidemiological data. We observed the co-circulation of multiple SARS-CoV-2 lineages over time, which were linked to multiple importations and characterized by large transmission clusters concomitant with a high number of infections. Subsequent implementation of a three-phase nationwide lockdown strategy greatly reduced infection numbers and hospitalizations. Yet we present evidence of sustained viral spread among sporadic clusters acting as "hidden reservoirs" during summer 2020. Mathematical modelling shows that increased mobility among residents eventually catalyzed the coalescence of such clusters, thus driving up the number of infections and initiating a new epidemic wave. Our results suggest that the efficacy of public health interventions is, ultimately, limited by the size and structure of epidemic reservoirs, which may warrant prioritization during vaccine deployment.

Identifiants

pubmed: 33883675
doi: 10.1038/s42003-021-02025-0
pii: 10.1038/s42003-021-02025-0
pmc: PMC8060392
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

489

Références

Nucleic Acids Res. 2017 Jul 3;45(W1):W567-W572
pubmed: 28520890
J Med Virol. 2020 Sep;92(9):1634-1636
pubmed: 32190908
Virus Evol. 2020 Aug 19;6(2):veaa061
pubmed: 33235813
J Med Virol. 2020 May;92(5):518-521
pubmed: 32022275
J Transl Med. 2020 Jun 23;18(1):251
pubmed: 32576227
Methods Ecol Evol. 2020 Aug;11(8):1002-1007
pubmed: 32983401
Euro Surveill. 2020 Feb;25(5):
pubmed: 32046819
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Infect Genet Evol. 2020 Sep;83:104351
pubmed: 32387564
Nature. 2021 Apr;592(7852):116-121
pubmed: 33106671
J Med Virol. 2020 Apr;92(4):455-459
pubmed: 31994738
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Bioinformatics. 2014 Nov 15;30(22):3276-8
pubmed: 25095880
Nat Commun. 2021 Jan 19;12(1):434
pubmed: 33469026
Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21825-9
pubmed: 20080801
J Med Virol. 2020 Oct;92(10):2232-2237
pubmed: 32492183
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
JMIR Public Health Surveill. 2020 Aug 10;6(3):e22853
pubmed: 32776889
Bioinformatics. 2018 Jul 15;34(14):2490-2492
pubmed: 29506019
Nat Med. 2020 Apr;26(4):450-452
pubmed: 32284615
Cell. 2020 Aug 20;182(4):812-827.e19
pubmed: 32697968
Bioinformatics. 2019 Feb 1;35(3):526-528
pubmed: 30016406
Mol Biol Evol. 2000 Jun;17(6):890-6
pubmed: 10833195
Nat Commun. 2011;2:321
pubmed: 21610724
Euro Surveill. 2020 Jun;25(24):
pubmed: 32583766
Science. 2020 Jul 31;369(6503):582-587
pubmed: 32513865
Ann Intern Med. 2020 May 5;172(9):577-582
pubmed: 32150748
J Virol. 2015 Dec 30;90(6):3253-6
pubmed: 26719272
Euro Surveill. 2020 Apr;25(13):
pubmed: 32265007
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
mBio. 2020 Jul 21;11(4):
pubmed: 32694143
Syst Biol. 2018 Jul 1;67(4):719-728
pubmed: 29432602
Cell. 2020 May 28;181(5):997-1003.e9
pubmed: 32359424
J Mol Biol. 1990 Oct 5;215(3):403-10
pubmed: 2231712
Am J Epidemiol. 2013 Nov 1;178(9):1505-12
pubmed: 24043437
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508

Auteurs

Marta Giovanetti (M)

Laboratório de Flavivírus, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Laboratório de Genética Celular e Molecular, ICB, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Medical Statistic and Molecular Epidemiology Unit, University of Biomedical Campus, Rome, Italy.

Eleonora Cella (E)

Burnett School of Biomedical Sciences, University of Central Florida, Orlando, FL, USA.

Francesca Benedetti (F)

Institute of Human Virology and Global Virus Network Center, Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, USA.

Brittany Rife Magalis (B)

Emerging Pathogens Institute & Department of Pathology, College of Medicine, University of Florida, Gainesville, FL, USA.

Vagner Fonseca (V)

Laboratório de Genética Celular e Molecular, ICB, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
Coordenação Geral dos Laboratórios de Saúde Pública/Secretaria de Vigilância em Saúde, Ministério da Saúde, (CGLAB/SVS-MS) Brasília, Distrito Federal, Brazil.

Silvia Fabris (S)

Medical Statistic and Molecular Epidemiology Unit, University of Biomedical Campus, Rome, Italy.

Giovanni Campisi (G)

Department of Molecular and Translational Medicine, Section of Microbiology, University of Brescia, Brescia, Italy.

Alessandra Ciccozzi (A)

Medical Statistic and Molecular Epidemiology Unit, University of Biomedical Campus, Rome, Italy.

Silvia Angeletti (S)

Unit of Clinical Laboratory Science, University Campus Bio-Medico of Rome, Rome, Italy.

Alessandra Borsetti (A)

National HIV/AIDS Researh Center, Istituto Superiore di Sanità, Rome, Italy.

Vittoradolfo Tambone (V)

Anthropology, and Applied Ethics, Campus Bio-Medico University, Rome, Italy.

Caterina Sagnelli (C)

Department of Mental Health and Public Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.

Stefano Pascarella (S)

Department of Biochemical Sciences "A. Rossi Fanelli", University of Rome "La Sapienza", Rome, Italy.

Alberto Riva (A)

ICBR, University of Florida, Gainesville, FL, USA.

Giancarlo Ceccarelli (G)

Department of Public Health and Infectious Diseases, Policlinico Umberto I Università 'Sapienza', Rome, Italy.

Alessandro Marcello (A)

Laboratory of Molecular Virology, International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.

Taj Azarian (T)

Burnett School of Biomedical Sciences, University of Central Florida, Orlando, FL, USA.

Eduan Wilkinson (E)

KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.

Tulio de Oliveira (T)

KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.

Luiz Carlos Junior Alcantara (LCJ)

Laboratório de Flavivírus, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Laboratório de Genética Celular e Molecular, ICB, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.

Roberto Cauda (R)

Department Infectious Diseases, - Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy.

Arnaldo Caruso (A)

Department of Molecular and Translational Medicine, Section of Microbiology, University of Brescia, Brescia, Italy.

Natalie E Dean (NE)

Department of Epidemiology, College of Public Health and Health Professions, University of Florida, Gainesville, FL, USA.

Cameron Browne (C)

Department of Mathematics, University of Lafayette, Lafayette, LA, USA.

Jose Lourenco (J)

Department of Zoology, University of Oxford, Oxford, UK.

Marco Salemi (M)

Emerging Pathogens Institute & Department of Pathology, College of Medicine, University of Florida, Gainesville, FL, USA. salemi@pathology.ufl.edu.

Davide Zella (D)

Institute of Human Virology and Global Virus Network Center, Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, USA. Dzella@ihv.umaryland.edu.

Massimo Ciccozzi (M)

Medical Statistic and Molecular Epidemiology Unit, University of Biomedical Campus, Rome, Italy. m.ciccozzi@unicampus.it.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH